SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 64 filers reported holding SIO GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $106 | – | 244 | +114.0% | 0.00% | – |
| Q3 2022 | $0 | – | 114 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 114 | -98.7% | 0.00% | – |
| Q1 2022 | $6,000 | -77.8% | 8,466 | -60.4% | 0.00% | – |
| Q4 2021 | $27,000 | -41.3% | 21,377 | +0.6% | 0.00% | – |
| Q3 2021 | $46,000 | – | 21,258 | +106190.0% | 0.00% | – |
| Q2 2021 | $0 | – | 20 | -28.6% | 0.00% | – |
| Q1 2021 | $0 | – | 28 | +1300.0% | 0.00% | – |
| Q4 2020 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
| Prosight Management, LP | 670,300 | $449,000 | 0.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
| ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
| Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
| Clearline Capital LP | 392,691 | $263,000 | 0.03% |
| APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
| Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
| NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |